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Prognostic factors of death in leptospirosis: a prospective 
cohort study in Khon Kaen, Thailand 
Thanachai Panaphut,(l) Somnuek Domrongkitchaiporn@ and Bandit Thinkamrop(3) 
Objectives: To determine the prognostic factors of death in leptospirosis. 
Methods: A prospective cohort study was conducted. One hundred and twenty one patients with clinically compatible 
leptospirosis, serologically confirmed, were recruited in this study. Clinical presentations and biochemical parameters 
on admission were selected as input variables for survival analysis. Multivariable Cox regression model was used to 
identify the prognostic factors of death. 
Results: Most patients were male (94.2%) with the mean &SD age of 38213.4 years; 77.4% of them were farmers. 
Among the 121 patients, 1206 patient-days were observed. Seventeen patients died. Overall mortality rate was 1.4 
per 100 patient-days (95% confidence interval [CI]: 0.9-2.3).Th e causes of death included: a) pulmonary hemorrhage 
in eight (47.1%) patients; b) complicated acute renal failure in three (17.6%) patients; c) multiple organ failure in 
three (17.6%) patients; d) acute respiratory distress syndrome in two (11.8%) patients, and e) irreversible shock in 
one (5.9%) patient. Four independent risk factors associated with the mortality were identified, including 
hypotension (relative risk [RR], 10.3; 95% CI, 1.3-83.2; PcO.05); oliguria (RR, 8.8; 95% CI, 2.4-31.8; PcO.01); 
hyperkalemia (RR, 5.9; 95% CI, 1.7-21; P<O.Ol), and presence of pulmonary rales (RR, 5.2; 95% CI, 1.4-19.9; 
PcO.05). 
Conclusion: The presence of oliguria, hyperkalemia, pulmonary rales, or hypotension on admission in patients with 
leptospirosis indicated high risk of death. Intensive care and early intervention should be provided for patients who 
present with these risk factors. 
Int J Infect Dis 2002; 6: 52-59 
INTRODUCTION 
Leptospirosis is caused by spirochetes of the genus 
Leptospira. The infection is acquired through contact 
with animal urine. Occupational activities that require 
prolonged contact with natural collections of free water, 
such as ponds, river branches, and marshes, are associ- 
ated with a greater risk of the infection. Leptospirosis is 
distributed worldwide but is most common in tropical 
and rural settings. The early clinical manifestation is 
often nonspecific and characterized by fever, chill, head- 
ache, and myalgia. Two classic forms of leptospirosis 
have been described: the anicteric form, which is mild 
and rarely associated with severe complications or 
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mortality, and the icteric form (Weil’s syndrome), which 
causes severe multisystem complications, such as 
hepatitis, renal insufficiency, bleeding diathesis, vascular 
instability, pulmonary hemorrhage, and encephalo- 
pathy.l Mortality from leptospirosis, mostly in icteric 
form, varies from 5% to 2O%.2-5. Multiple risk factors 
associated with death, such as older age, oliguria or renal 
insufficiency, dyspnea or respiratory insufficiency, 
presence of pulmonary infiltration, pulmonary hemor- 
rhage, leukocytosis, high serum bilirubin level, abnormal 
electrocardiogram, and altered mental status, have been 
reported.3,6-11 Because of the high mortality and the 
shortage of medical resources in most endemic areas, a 
guideline is needed for physicians to identify severe or 
high-risk cases, which need early admission or transfer 
to well-equipped hospitals. Close observations and 
intensive care may prevent complications and avoid 
death in a particular subgroup of patients. Limited pros- 
pective studies have been conducted to determine 
factors associated with death. Most previous studies 
were done retrospectively without the time course of the 
disease being taken into account. We therefore con- 
ducted this prospective, multivariate analysis based on 
clinical parameters and laboratory findings on admission 
to determine factors associated with death from lepto- 
spirosis. 
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MATERIALS AND METHODS 
Subjects 
This study was conducted in Khon Kaen General 
Hospital, a tertiary care hospital in the northeastern part 
of Thailand, between June 1999 and December 1999. 
Diagnosis of leptospirosis was based on the World 
Health Organization (WHO) criteria for leptospirosis 
diagnosis12 and serologically proven leptospirosis using 
an IgM-specific LEPTO dipstick assay (titer >1:100).13 
Serovars of leptospirosis were identified by a micro- 
scopic agglutination test. 14,15 Patients who had concurrent 
systemic infection, such as respiratory tract infection, 
bacterial septicemia, malaria, and rickettsial infection, 
were excluded from this study. Children, who contri- 
buted less than 5% of the total leptospirosis patients in 
this hospital, were also excluded. Two hundred and 
seventy six patients were admitted to the hospital because 
of acute febrile illness and suspicion of leptospirosis. 
However, only 121 cases met the study criteria and 
formed the cohort. They were then followed until they 
died or for two weeks after discharge from the hospital. 
Data collection 
Patients’ characteristics, presenting symptoms, previous 
antibiotic use, and physical findings were recorded on 
admission. Blood samples were obtained on admission 
for determination of the following parameters: hemo- 
globin, hematocrit, complete blood count, blood urea 
nitrogen, serum creatinine, serum electrolyte, creatine 
phosphokinase (CPK), albumin, aspartate transaminase 
(AST), total bilirubin, and alkaline phosphatase; a co- 
agulogram was performed for prothrombin time and 
partial thromboplastin time. Blood samples for hemo- 
culture, thick and thin film for malaria, IgM-specific 
LEPTO dipstick assay, and dot blot immunoassay for 
the rapid diagnosis of rickettsial infection were also 
obtained.16 The WHO criteria for leptospirosis diagnosis 
was recorded. The severity of the disease in the first 24 
hours of admission was also assessed using a modified 
APACHE II scoring system. The modified APACHE II 
score was basically the same as the original APACHE II 
except that the information on oxygenation was not 
included as this was not performed routinely on admis- 
sion unless there was an indication.17 The modified 
APACHE II score was assessed and recorded by a well- 
trained nurse. The identification of organ involvement 
by leptospirosis was performed on admission by two 
internists. If there were discrepancies between the two 
internists, a third internist would be consulted for a final 
decision. Definitions of organ involvement and indi- 
cations for treatment were presented in the appendix. 
Severe cases of leptospirosis, defined by the presence 
of acute renal failure (serum creatinine >2 mg/dl), 
unstable vital signs, or multiple organ failure were 
treated with 1.5 million unit of intravenous sodium 
penicillin G, every 6 hours. l* The antibiotic was switched 
to 500 mg of oral amoxycillin thrice daily when the 
patients were free of fever and clinically improved for at 
least 24 hours. For mild cases of leptospirosis, 100 mg of 
oral doxycycline twice daily was given for seven days.19 
Intravenous third generation cephalosporin were given 
initially in 16 patients before severe bacterial infection 
could be excluded. The antibiotic was then switched to 
sodium penicillin G when the diagnosis of leptospirosis 
was confirmed. Fifty-nine patients (48.7%) had received 
at least one dose of antibiotics, including sodium penicillin 
G, ampicillin, doxycycline, amoxycillin, or third gener- 
ation cephalosporin before admission. Supportive care, 
including intravenous fluid infusion, respirator support, 
blood component transfusions, vasopressors, dialysis, 
and other medications were provided as needed. All 
patients were requested to return for follow up at 2 
weeks after discharge. 
Statistical analysis 
Continuous data were presented as mean *SD. 
Unpaired t-test was used to test for the difference of the 
means between two studied groups, survivors and 
nonsurvivors. Categorical data were presented as 
proportions. Chi square test and Fisher’s exact test were 
used to test the difference of the proportion between the 
two groups as appropriate. The Kaplan-Meier survival 
method was used to estimate survival probability. Onset 
was the date when the first symptom presented, and the 
end of study was the date when the patient died or was 
still alive at two weeks after discharge. The event of 
interest was death from leptospirosis. Patients were 
discounted if they still were alive at two weeks after 
discharge. Patient survival was related to multiple 
potential risk factors, including age (>29,29-48 or ~48 
years), interval between the first symptoms and admis- 
sion (> or 14 days), previous antibiotic use, the presence 
of hemorrhagic symptoms, neurological symptoms, 
Table 1. Percentage of presenting symptoms of survivors, non- 
survivors, and total patients 
Presenting symptoms 
Fever 
Myalgia 
Headache 
Chill 
Hemoptysis 
Jaundice 
Conjunctival suffusion 
Hypotension 
Tachypnea 
(RR z 28/min) 
Oliguria 
(urine<400cdday) 
Non- 
survivors Survivors Overall 
(n=17) (n=104) (n=721) 
100.0 100.0 100.0 
100.0 95.2 95.9 
88.2 89.4 89.3 
82.4 77.0 77.7 
29.4 22.5 23.5 
88.2 49.0* 54.5 
52.9 52.9 52.9 
94.1 44.2* 51.2 
70.6 18.3” 25.6 
76.5 12.5* 21.5 
*P<O.O5 when compared to non-survivors. 
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hemoptysis, bilateral pulmonary rales, hypotension that 
required vassopressor infusion, oliguria, respiratory rate 
(> or 528 times/min), hematocrit (< or ?32%), leuko- 
cyte counts (> or <13,000/mm3), platelet counts (< or 
2 100,000/mm3), creatinine (> or 55 mg/dl), potassium 
(> or 55 mg/dl), total bilirubin (> or 19 mg/dl), 
aspartate transaminase (> or 580 IU/L), albumin level 
(< or 22.9 g/dl), creatine phosphokinase (> or 1440 
IU/L), and modified APACHE II score (> or 515). 
Univariate analysis of the potential risk factors was 
done by univariate Cox regression analysis and log rank 
test. Each factor was presented as incidence rate (per 
100 patient-days), relative risk (hazard ratio) and 
its 95% CL Multivariable Cox regression model was 
performed to determine factors affecting patient’s 
survival, taking into account effects of several potential 
factors simultaneously. Input variables for the multi- 
variable analysis were selected from significant variables 
obtained from the univariate analysis. Linearity of 
continuous variables were explored and dichotomized, 
using mean as the cutoff point, before the model fitting. 
The linear variables included respiratory rate, 
hematocrit, leukocyte counts, serum creatinine, total 
bilirubin, aspartate aminotransferase, albumin level and 
serum creatine transaminase. Age was the only non- 
linear variable and was then categorized into three 
groups based on the reverse U-shaped curve of the 
relationship between age and log hazard. The model was 
fitted using backward elimination method. The signifi- 
cance of each variable in the model was determined 
using partial likelihood ratio test. Model assumption and 
adequacy was assessed for the final model. 
RESULTS 
Baseline characteristics 
Among the 121 definite cases of leptospirosis (114 males 
and 7 females), 74.4% were farmers, aged 38t13.4 years. 
Most of them experienced prolonged water contact in 
rice fields. The WHO criteria for leptospirosis diagnosis 
was 22.2k3.1. The presenting symptoms and laboratory 
findings on admission are shown in Tables 1 and 2, 
respectively. Mean *SD duration between the date of 
the first symptom related to leptospirosis and the date 
at admission was 5+2.2 days. Based on organ involve- 
ment, the clinical presentations of leptospirosis could be 
categorized into four clinical syndromes: a) fever with 
jaundice and renal failure, Weil’s syndrome, (60.3%); b) 
fever with renal failure (14.9%); c) fever with jaundice 
(4.1%); and d) f ever alone, without either jaundice and 
renal failure (20.7%). Almost all patients were healthy 
prior to the infection. Only two (1.6 %) patients had 
diabetes mellitus. 
Serovars of leptospira species 
Information on the serovars was available in only 35 
patients (28.9%). The serovars were L. sejroe in 21 
patients (60%), L. brutisluva in eight patients (22.8%) 
L. bangkoki in three patients (8.4%), L. pyrogenese 
in two patients (5.8%), and L. copenhageni and L. 
icterohaemorrhagia in one patient each (2.9%). There 
were also combined infections with two serovas, L. 
sejroe and L. bratislava in two patients (5.8%), and 
L. sejroe and L. pyrogenese in one patient (2.9%). 
Organ dysfunctions 
Thrombocytopenia, platelet count < 100,000 cells/mm3, 
was the most frequent organ dysfunction found in this 
study (78.6%). Other organ involvement included acute 
renal failure (74.2%), hepatitis (65.3 %), hypotension 
requiring dopamine therapy (51.6%) congestive heart 
failure (28.2%) pulmonary hemorrhage (9.1%) and 
acute respiratory distress syndrome or ARDS (3.4%). 
Most patients with acute renal failure were nonoliguric 
type (80.4% of all patients with renal failure). Volume 
depletion was found to be the major contributing factor 
Table 2. Laboratory findinqs on admission for survivors, non-survivors, and all patients 
Laboratory values 
Hematocrit (%) 
Leukocyte count (log/L) 
Platelet count (log/L) 
Urea nitrogen (mg/dl) 
Creatinine (mg/dl) 
Sodium (mmolll) 
Potassium (mmol/l) 
Bicarbonate (mmol/l) 
Albumin (g/dl) 
Total bilirubin (ma/d0 
AST (IU/L) - 
CPK (M/L) 
The modified APACHE II score 
Non- 
survivors 
(n=17) 
29.155.4 
16.5~6.7 
56.0261.1 
93.0242.5 
7.822.5 
131.727.4 
4.7k1.5 
13.3k3.8 
2.720.4 
15.5k10.8 
131.8~123.5 
941.4+1092.6 
17.352.4 
Survivors 
(n= 104) 
Overall 
(f-t= 121) 
32.7*6.6* 
12.7?5.2* 
68.7~656 
62.1?35.2* 
4.6k2.9" 
133.5~5.2 
3.5~0.6" 
18.1+3.9* 
3.0+0.5* 
9.1*9.9* 
75.6+56.6* 
367.8?454.9* 
10.1*4.7* 
32.2k6.6 
13.225.5 
66.9265.2 
66.9237.9 
5.1t3.1 
133.2e5.4 
3.720.9 
17.3k3.8 
2.9-co.5 
9.3e9.7 
82.5269.9 
436.7k591.2 
11.1~5.1 
*P<O.O5 when compared to non-survivors 
4 
0 7 10 14 20 30 40 
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Figure 1. Kaplan-Meier survival curve for patients with 
leptospirosis infection. Numbers under the curve represent 
number at risk at the corresponding follow-up time. 
of acute renal failure (41.6%). Only 12 patients (13.3% 
of all patients with renal failure) needed renal replace- 
ment therapy. Although renal failure was the most 
common complication, almost all patients with renal 
failure (96%) had complete recovery. Serum creatinine 
declined to <2 mg/dl within two weeks in the majority 
of cases. There was no significant difference in serum 
creatine phosphokinase between renal failure patients 
who needed (695.1k609.9 mg/dl) and who did not need 
(482.5k656.7 mg/dl) dialysis (P>O.O5). There was a 
significant correlation between serum potassium and 
serum creatine phosphokinase (RR=0.44, P<O.Ol). 
Level of serum aspartate transaminase and total 
bilirubin were significantly higher, but serum albumin 
was significantly lower in nonsurvivors than in survivors 
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(Table 1). Only five patients with hepatitis had 
coagulopathy (international normal ratio >1.5 times). 
Fifteen patients (12.4%) had severe hypoalbuminemia 
(albumin ~2.5 g/dl). The majority of patients with 
hypoalbuminemia recovered (serum albumin 24 g/dl) 
within two weeks after admission. Congestive heart 
failure was common and related mostly to excessive 
intravenous fluid administration in the presence of 
impaired renal function. High doses of furosemide 
therapy was required to induce diuresis. Pulmonary 
hemorrhage usually developed in the first week of 
illness. All these patients needed intubation and 
respiratory support. ARDS developed in four patients 
within the first week of admission. Five (4.1%) patients 
presented with generalized seizure; three of them 
needed immediate dialysis. Only seven (5.8%) patients 
had severe alteration of consciousness. 
Outcomes and mortality 
Among the 121 patients, 1206 patients-days were 
observed. Seventeen patients died. Overall mortality 
rate was 1.4 per 100 patient-days (95% CI: 0.9-2.3). 
Among the 104 patients who survived, fever subsided 
within 4-+3.2 days after admission. Most of them (95%) 
had remarkable improvement after antibiotic therapy 
and appropriate supportive care. Of these, the duration 
from the onset of the first symptom to the end 
of hospitalization was 9.9~4.3 days. Ninety patients 
(86.5%) attended the hospital for follow up, whilst 
the remaining 14 patients (16.5%) reported their own 
physical conditions either by telephone or by mail at 
the in the second week after discharge. In the group of 
Table 3. Unadjusted relative risk for each selected factors on death 
Factors 
Patient Incidence Relative 
days rate (%) risk 95% CI P-value* 
Age (year) 
~28 
29-48 
>48 
Delay time >4 days 
Previous antibiotic use 
Hemoptysis 
Hemorrhagic symptoms 
Neurological symptoms 
Tachypnea (resp. rate z28/min) 
Bilateral pulmonary rales 
Hypotension (dopamine use) 
Oliguria (urine ~400 cc/day) 
Hematocrit ~32% 
WBC counts >13,000/mm3 
Platlet counts < 1 00,000/mm3 
Creatinine >5 mg/dl 
Hvperkalemia (K>5 mmolll) 
Tdial bilirubin >9 mg/dl 
AST <8OIlJ/L 
Albumin c2.9 q/dl 
289 
601 
316 
678 
875 
292 
402 
222 
313 
447 
644 
247 
533 
613 
969 
656 
67 
488 
538 
494 
0.7 
1.8 
1.3 
1.4 
1.6 
1.7 
1.4 
0.9 
3.8 
3.1 
2.5 
5.3 
2.3 
2.1 
1.4 
2.3 
10.4 
2.0 
2.0 
2.4 
1 - 
2.7 0.6, 12.2 
1.9 0.3, 10.2 
1.0 0.4. 2.7 
1.7 0516.1 
1.4 0.5, 3.8 
1.0 0.4, 2.9 
0.6 0.1, 2.6 
6.9 2.4, 9.7 
7.9 2.3, 27.6 
13.5 
14.5 
3.0 
3.2 
1.0 
6.0 
14.2 
2.1 
2.3 
3.5 
1.8,.101.9 
4.7, 44.6 
1.1, 8.6 
1, 9.9 
0.3, 3.6 
1.4, 26.6 
5.2, 38.6 
0.8, 5.6 
0.8, 6.2 
1.2. 9.9 
- 
0.201 
0.476 
0.983 
0.378 
0.571 
0.910 
0.470 
<O.OOl 
<O.OOl 
0.001 
<O.OOl 
0.028 
0.031 
0.958 
0.006 
<O.OOl 
0.123 
0.093 
0.012 
- CPK>440lU/L 499 
Modified APACHE II score >I5 243 
*P-value of Wald-test from univariate Cox-regression model. 
2.6 5.1 1.6;15.8 0.005 
4.9 1.4 1.2, 1.6 -c0.001 
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patients who died, the duration of hospital stay was 
2.443 days. The associated causes of death included: a) 
pulmonary hemorrhage in eight (47.1%) patients, b) 
complicated acute renal failure, associated with hyper- 
kalemia and fluid overload in three (17.6%) patients, 
c) multiple organs failure (circulatory failure, renal 
failure, respiratory failure, and encephalopathy) in three 
(17.6%) patients, d) acute respiratory distress syndrome 
in two (11.8%) patients, and e) irreversible shock in one 
(5.9%) patient. Pulmonary involvement of leptospirosis 
was the main cause of death. Nine patients (81.8% 
of patients with pulmonary hemorrhage) died in the first 
three days of admission despite aggressive medical 
support in ICU. Only two patients with pulmonary 
hemorrhage survived. Alveolar infiltration demon- 
strated by chest x-rays of the two survivors were 
completely resolved in the second week after the 
development of this complication. The death rate was 
20.6% for patients with Weil’s syndrome, 6.7% for 
patients with renal failure without jaundice, and 
0.0% for patients without renal failure. The modified 
APACHE II score was significantly higher in non- 
survivors than in survivors (Table 1). There was no 
mortality for patients with modified APACHE II score 
of = 10 or less. By contrast, the mortality was 12.5 % for 
patients with score between 11 and 15, rising to 48% 
when the score was >1.5. 
Survival analysis and prognostic factors 
The first death occurred at day 4 after the onset of the 
first symptom and there was no death beyond day 18 
(Figure 1). The probability of survival at day 7 and at 
day 14 was 91.4% (95% CI: 84.5-95.3%) and 82.7% 
(95% CI: 72.1~89.5%) respectively. Eleven risk factors 
associated with death were identified based on 
univariate Cox regression model. These included the 
presence of tachypnea, bilateral pulmonary rales, 
hypotension, oliguria, hematocrit >32%, leukocyte 
counts > 13,000/mm3, creatinine >5 mg/dl, potassium 
>5 mmol/l, albumin >2.9 g/dl, creatine phosphokinase 
>440 IU/L, and a modified APACHE II score of >15 
(Table 3). After fitting the model as described in 
methods, only four factors were found statistically 
significantly associated with death. These included the 
presence of oliguria, bilateral pulmonary rales, hyper- 
kalemia, and hypotension (Table 4). 
DISCUSSION 
Leptospirosis is a re-emerging disease in Thailand, 
especially in the northeast. The incidence has progres- 
sively increased for the past few years, starting from 
0.6/100,000 in 1996, 4.7/100,000 in 1998 to 9.3/100,000 
population in 1999.20 The disease affects mostly adult 
male farmers who spent most of their working time in 
rice fields where prolonged water contact is unavoid- 
able. The spreading of leptospirosis occurs during the 
rainy season every year, starting from June through to 
November. Apart from the rapidly growing incidence, 
the severity and the clinical characteristics are changing. 
In the past, mortality as well as pulmonary hemorrhage 
and ARDS were unusual for patients who could access 
medical services in Thailand.21 
The mortality from leptospirosis ranged from 5% 
to 20% in previous reports.2,22,23 The discrepancy in 
mortality is attributed to different criteria for patient 
inclusion and to the severity of leptospirosis. The 
mortality rate was rather high in this study, almost 15 %. 
The estimated one- and two-week survival rates were 
approximately 90% and SO%, respectively. The severity 
of the disease is unlikely to be related to a delay 
in hospitalization, because we found no association 
between the delay of admission time and mortality. 
The reasons for the rapidly growing incidence and 
the alteration in its severity are still unclear. The 
alteration in the serovars has been postulated as a cause 
of the changing clinical manifestation.24 In the past, 
L. bataviae and L. icterohemorrhagiae were the most 
common serovars isolated from affected patients in this 
area2r whereas L. sejroe and L. bratislava were the two 
most frequent serovars found in this study. It is 
unfortunate that second blood samples for the identifi- 
cation of serovars were available in only one third of our 
cases. This finding precludes further analysis on the 
relationship between serovars and the outcomes. The 
variation in the severity of disease between studies 
could be due to the differences in study designs, popu- 
lations, and serovars. In our study, mortality rate may be 
overestimated because of selection bias, since our 
hospital is a referral center for most nearby community 
hospitals. However, the overestimation is believed to be 
minimal, since all patients were treated with experi- 
enced personnel in well-equipped intensive care 
facilities, and the study is valid on its own in determining 
factors affecting patient survival. 
Table 4. Unadjusted and adjusted relative risk of death for each selected factor using Cox-regression 
model. Only significant risk factors in Table 3 were selected for the analysis 
Factors 
Unadjusted Adjusted 
RR RR 95% Q P* 
Pulmonary rales 7.9 5.2 1.4, 19.9 0.015 
Hypotension (dopamine use) 13.5 10.3 1.3 , 83.2 0.029 
Oliguria (urine ~400 cc/day) 14.5 8.8 2.4 , 31.8 0.001 
Hyperkalemia (K25 mmolll ) 14.2 5.9 1.7, 21.0 0.006 
*P-value from partial likely hood ratio test 
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Several risk factors for death from leptospirosis 
have been identified in previous studies.3,6-11 In our 
present study, a prospective, multivariable analysis to 
identify independent risk factors of death was done. 
Factors that were included in the analysis based on 
initial clinical and biochemical parameters were 
obtained routinely on admission in order to develop an 
initial guideline for physicians to assess the severity of 
the disease. Subjective symptoms and biochemical 
parameters that were occasionally obtained in medical 
wards were excluded from our analysis. Additional organ 
involvement or biochemical changes that developed 
subsequently after the first day of admission were also 
excluded. Cox regression model revealed that the 
presence of hypotension, oliguria, hyperkalemia, and 
bilateral pulmonary rales were the four risk factors 
associated with death in leptospirosis. The presence of 
one or more of these risk factors should alert physicians 
to provide close monitoring and proactive management 
for all potential complications of leptospirosis. These 
four parameters are simple and can be obtained in most 
hospital settings.The biochemical markers that indicated 
the severity of hepatitis, including bilirubin and serum 
aspartate transaminase, were not independent risk 
factors of death in our analysis 
Our findings are comparable to the findings from 
the DuPont et al. study in many aspects7 In their study, 
a retrospective analysis of 56 leptospirosis patients over 
a period of five years, five factors were independently 
associated with mortality: dyspnea, oliguria, elevated 
white blood cell, abnormal ECG, and alveolar infil- 
tration on chest radiograph. By contrast, cardiovascular 
collapse and hyperkalemia were not associated with 
higher mortality in their study. 
Hypotension or cardiovascular collapse on admis- 
sion, which was associated with the highest relative risk 
of death in our study, might reflect the presence of 
hypovolemia, increased vascular permeability, or poor 
myocardial function. 25,26 Oliguria reflected the presence 
of severe renal failure, severe volume depletion, or very 
poor renal perfusion. Renal failure, a common compli- 
cation of leptospirosis, affected one third of the cases in 
our study.6,27-29 The majority of cases were nonoliguric 
type and had spontaneous recovery without the need of 
dialysis. Judicious fluid replacement in the early stage of 
disease is mandatory, as volume depletion is a common 
contributing factor to the development of acute renal 
failure. 
The clinical picture and outcome of renal failure in 
our study were similar to that reported by Seguro et a1.6 
In our study, however, more than 10% of renal failure 
patients still needed a short period of dialysis. There was 
no relationship between the severity of rhabdomyolysis 
and the severity of renal failure, suggested by the lack of 
difference in the initial serum creatine phosphokinase in 
patients who needed and those who did not needed 
dialysis. The latter finding contradicts the findings from 
the Marotto et al. study where rhabdomyolysis was 
found to be a contributing factor to the development of 
renal failure.lO In this study, there was a correlation 
between creatine phosphokinase level and the maxi- 
mum serum creatinine level. However, the correlation 
between serum creatinine and degree of rhabdomyolysis 
may be misleading. Serum creatinine is a metabolite of 
muscle creatine. Elevation in serum creatinine could 
result from both rhabdomyolysis and the impaired renal 
function. The presence of renal failure in leptospirosis 
patients should receive special attention when it is 
accompanied by jaundice (Weil’s syndrome) because it 
is the clinical syndrome most associated with risk of 
death. In the absence of jaundice, the risk of death in 
renal failure patients was much lower, but it still 
existed.30.31 There was no mortality in patients who had 
no renal failure in our study. Hyperkalemia, the third 
independent risk factor in our study, may reflect exten- 
sive cellular damage, resulting in massive potassium 
leakage into the systemic circulation, in addition to the 
presence of renal failure. 
The presence of bilateral diffuse pulmonary rales, 
the last independent risk factor in our study, may be 
associated with congestive heart failure, pulmonary 
hemorrhage, ARDS, or interstitial pneumonitis caused 
by leptospirosis. 32,33 Pulmonary manifestations are 
frequently observed in patients with leptospirosis. The 
incidence varies from 20 to 70%, depending on the 
studies.3k36 Pulmonary hemorrhage and ARDS are two 
of the most severe complications of leptospirosis. This 
association has been recognized in the last 20 years.37,38 
Pulmonary hemorrhage and ARDS were the predomin- 
ant complications associated with death, involving 60% 
of all mortality in our study, followed by complicated 
renal failure and multiple organ failure. 
The modified APACHE scoring system, which 
included multiple clinical and laboratory parameters 
that were also used for the relative risk analysis, were 
not considered as another independent risk factor in our 
model. However, the scoring system is simple and 
familiar to most physicians. It also provides a graded 
assessment of the risk of death from leptospirosis. We, 
therefore, suggest that the modified APACHE II scoring 
system may be an alternative indicator for the assess- 
ment of severity in leptospirosis. For patients with high 
modified APACHE II score, intensive care and early 
management to prevent complications should be 
provided. 
CONCLUSIONS 
Leptospirosis is a re-emerging infectious disease in 
Thailand, with rapidly increasing incidence . The disease 
affects predominantly adult male farmers, who have 
history of prolonged water contact, and is associated 
with more severe clinical manifestations and higher 
mortality than in the past. Pulmonary hemorrhage and 
ARDS are the most common complications associated 
with death nowadays. The presence of hypotension, 
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oliguria, hyperkalemia, or bilateral diffuse pulmonary 
rales on admission indicates a poor prognosis for the 
patients and the need for intensive care. 
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APPENDIX 
Clinical definition 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
Acute renal failure was defined by the presence of 
serum creatinine of >2 mg/dl. 
Oliguria was defined by the presence of first 24 
hours urine volume of ~400 ml. 
Pulmonary hemorrhage was defined as frank 
hemoptysis or frank blood from an endotracheal 
tube with at least two of the following: 
decreased hematocrit over 3% without other 
explainable source of bleeding; 
no clinical signs of volume overload (‘jugular venous 
pulsation <5 cm above sternal angle, or central 
venous pressure < 12 cm; 
chest x-ray showing unilateral or bilateral alveolar 
infiltration with normal cardiothoracic ratio. 
Congestive heart failure was defined by the presence 
of at least two of the following: 
clinical signs of left ventricular dysfunction (JVP > 6 
cm above sternal angle, pulmonary rales, hepatic 
pulsation, or S3 galloping); 
central venous pressure > 15 cm (if indicated) 
chest x-ray showing diffuse alveolar pattern and 
increased cardiothoracic ratio. 
Acute respiratory distress syndrome (ARDS) was 
defined by the presence of the following criteria: 
no clinical signs of congestive heart failure as 
defined above; 
arterial gas exchange index of PO2/FiO2 ~200; 
chest x-ray showing diffuse alveolar process with 
normal cardiothoracic ratio; 
pulmonary capillary wedge pressure of ~18 mmHg. 
Jaundice was defined as frank icteric sclera or serum 
total bilirubin of >3 mg/dl. 
Cardiovascular collapse was defined as systolic BP 
~90 mmHg and needing vasopressors to maintain 
blood pressure. 
Neurological symptoms were defined by the 
presence of either alteration of consciousness 
(Glasgow Coma Score ~13) or seizure. 
Hemorrhagic symptoms were defined by the 
presence of at least one of the following: epistaxis, 
gum bleeding, gross hematuria, or upper gastro- 
intestinal hemorrhage. 
Indication for treatment 
Dialysis therapy was initiated when one of the following 
conditions was present: 
l intractable hyperkalemia ([K+] >6.5 mmol/l); 
. intractable acidemia; 
. clinically significant pulmonary edema; 
. uremic encephalopathy; 
. uremic pericarditis; 
. oliguria (urine output ~200 ml/12 h) and BUN 
> 100 mg/dl. 
Ventilatory support was started when one of the 
following criteria was present: 
. respiratory rate >35 breaths/min when a patient 
was ventilated with facemask 8-10 L/min of 100% 
oxygen; 
l hypoxemia was defined by the presence of arterial 
oxygen saturation ~95% even FiO2BO.6; 
. cyanosis; 
l deterioration of consciousness with respiratory rate 
>30 breaths/min. 
Dopamine infision was started when a patient had 
hypotension (BP<90/60 mmHg) after fluid resuscitation 
as needed for maintain vital signs. 
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